Cargando…
Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever
Salmonella Typhi and Salmonella Paratyphi A are the leading causative agents of enteric fever which cause morbidity and mortality worldwide. Currently, there is no combination vaccine which could protect infection from both the strains. In this paper, we are focusing on the development of a novel bi...
Autores principales: | Howlader, Debaki R., Koley, Hemanta, Sinha, Ritam, Maiti, Suhrid, Bhaumik, Ushasi, Mukherjee, Priyadarshini, Dutta, Shanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138408/ https://www.ncbi.nlm.nih.gov/pubmed/30216367 http://dx.doi.org/10.1371/journal.pone.0203631 |
Ejemplares similares
-
An Experimental Adult Zebrafish Model for Shigella Pathogenesis, Transmission, and Vaccine Efficacy Studies
por: Howlader, Debaki R., et al.
Publicado: (2022) -
Controlling the bacterial load of Salmonella Typhi in an experimental mouse model by a lytic Salmonella phage STWB21: a phage therapy approach
por: Mondal, Payel, et al.
Publicado: (2023) -
A Bivalent MAPS Vaccine Induces Protective Antibody Responses against Salmonella Typhi and Paratyphi A
por: Zhang, Fan, et al.
Publicado: (2022) -
Genetic Diversity of Salmonella enteric serovar Typhi and Paratyphi in Shenzhen, China from 2002 through 2007
por: Wu, Weiyuan, et al.
Publicado: (2010) -
Salmonella Typhi and Salmonella Paratyphi A elaborate distinct systemic metabolite signatures during enteric fever
por: Näsström, Elin, et al.
Publicado: (2014)